Effects of iloprost and sildenafil treatment on elabela, apelin-13, nitric oxide, and total antioxidant and total oxidant status in experimental enzyme-positive acute coronary syndrome in rats

dc.contributor.authorAydin, S.
dc.contributor.authorKuloglu, T.
dc.contributor.authorAydin, Y.
dc.contributor.authorYalcin, M. H.
dc.contributor.authorUgur, K.
dc.contributor.authorAlbayrak, S.
dc.contributor.authorAydin, S.
dc.date.accessioned2026-08-12T17:05:22Z
dc.date.issued2020
dc.departmentFırat Üniversitesi
dc.description.abstractDespite significant advances in medicine, mortality due to cardiovascular disease is not yet preventable. We investigated the amounts of elabela (ELA) and apelin, synthesized by cardiomyocytes, and changes of these compounds in cardiac tissue and circulation after administration of iloprost (ILO) and sildenafil (SIL) in rats with induced myocardial ischemia (MI). We also investigated a connection with circulating troponin-I, creatine kinase (CK), creatine kinase-myocardial band (CK-MB) and nitric oxide (NO), and total anti-oxidant (TAS)/total oxidant status (TOS). We established eight study groups of five rats each. Group 1, sham, was given only physiologic serum; group 2, ILO; group 3, SIL; group 4, ILO + SIL; group 5, MI; group 6, MI + ILO; group 7, MI + SIL; group 8, MI + ILO + SIL. Troponin-I, CK, CK-MB and TAS-TOS were investigated using an autoanalyzer. NO, ELA and apelin were analyzed by ELISA. Tissue apelin and ELA expressions and localizations were determined by immunohistochemistry. The MI group compared to the control (sham) group showed that ELA, apelin, troponin-I, CK, CK-MB, NO and TOS levels were elevated significantly. Concentrations of these factors increased in MI, but decreased after ILO and SIL administration. The largest decrease of TOS was identified in the ILO + SIL group. ELA and apelin may be novel indicators of MI and administration of ILO and SIL, individually or together, may be useful for treating MI.
dc.identifier.doi10.1080/10520295.2019.1653497
dc.identifier.endpage151
dc.identifier.issn1052-0295
dc.identifier.issn1473-7760
dc.identifier.issue2
dc.identifier.orcid0000-0001-9874-3838
dc.identifier.orcid0000-0003-4028-2041
dc.identifier.orcid0000-0002-0559-8932
dc.identifier.pmid31429306
dc.identifier.scopus2-s2.0-85070942361
dc.identifier.scopusqualityQ2
dc.identifier.startpage145
dc.identifier.urihttps://doi.org/10.1080/10520295.2019.1653497
dc.identifier.urihttps://hdl.handle.net/11508/49088
dc.identifier.volume95
dc.identifier.wosWOS:000482430100001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofBiotechnic & Histochemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectAntioxidant
dc.subjectapelin-13
dc.subjectelabela
dc.subjectiloprost
dc.subjectmyocardial ischemia
dc.subjectoxidant
dc.subjectsildenafil
dc.titleEffects of iloprost and sildenafil treatment on elabela, apelin-13, nitric oxide, and total antioxidant and total oxidant status in experimental enzyme-positive acute coronary syndrome in rats
dc.typeArticle

Dosyalar